Health Condition 1: I00-I99- Diseases of the circulatory system
Conditions
Interventions
Intervention1: INTRATHECAL ROPIVACAINE 0.75% HEAVY: In patients belonging to group Ropivacaine, 22.5mg(3mL) of 0.75% hyperbaric Ropivacaine will be administrated intrathecally in L3-L4 space. Monitori
Sponsors
DR NIKITHA STEPHEN
Eligibility
Inclusion criteria
Inclusion criteria: patients of ASA 1 and 2 physical status, infra umbilical surgeries lasting less than 2 hours
Exclusion criteria
Exclusion criteria: patients with allergic history to local anaesthetics, local site skin infection, bleeding and coagulation disorders, pregnancy, spine deformities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To measure and compare the time taken for complete motor regression produced with intrathecal 15mg 0.5% hyperbaric Levobupivacaine vs intrathecal 22.5mg 0.75% hyperbaric RopivacaineTimepoint: At baseline, 5mins,10mins,15mins,30mins,1hour,1:30hours,2hours,2:30hours,3hours and postoperatively 30min,1hour,1:30hours,2hours | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Time taken for onset of spinal anaesthesia 2)Maximum sensory blockade level 3)Time taken to achieve maximum sensory blockade level 4)Change in hemodynamic parameters among both the groups 5)Time taken for unassissted ambulation 6)Time taken for voiding urineTimepoint: ONSET OF MOTOR BLOCK -5,10,15,30,45 mins ONSET OF SENSORY BLOCK - 2,4,6,8,10,15,20,25,30,35 mins HEMODYNAMICS - baseline,2,5,10,15,20,25,30mins,1hr,1.5hrs,2hrs | — |
Countries
India
Contacts
Public ContactDR NIKITHA STEPHEN
Mahatma Gandhi medical college and research institute, Pillayarkuppam, Pondicherry
Outcome results
None listed